ArticleClinical and molecular hepatology2026

A cost-effectiveness evaluation framework for treatment for metabolic dysfunction-associated steatohepatitis: Potential and concerns: Editorial on "Evaluating treatment response thresholds for cost-effective treatment in metabolic dysfunction-associated steatotic liver disease".

Sherlot Juan Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.